Dr. Dante Anthony Implicito, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 113 W Essex St Ste 201, Maywood, NJ 07607 Phone: 201-251-7725 Fax: 201-251-2599 |
Dr. Julie Michelle Keller, MD Orthopaedic Surgery - Orthopaedic Trauma Medicare: Accepting Medicare Assignments Practice Location: 113 W Essex St, Suite 201, Maywood, NJ 07607 Phone: 201-226-0145 Fax: 201-226-0147 |
Dr. Janet Han Yueh, MD Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 W Essex St Ste 202, Maywood, NJ 07607 Phone: 201-487-3400 Fax: 201-487-2481 |
Dr. Stephen R Lindholm, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 113 W Essex St, Suite 201, Maywood, NJ 07607 Phone: 201-226-0145 Fax: 201-226-0147 |
News Archive
Kaiser Health News staff writer Chris Weaver reports on developments surrounding efforts in the Senate regarding legislation on Medicare payments to physicians. "Legislation to 'fix' Medicare's physician payment formula has stalled in the Senate, just days after Majority Leader Harry Reid, D-Nev., announced his intent to fast-track the measure.
Washington State University researchers have found an unlikely recipe for antibiotic resistant bacteria: Mix cow dung and soil, and add urine infused with metabolized antibiotic. The urine will kill off normal E. coli in the dung-soil mixture. But antibiotic-resistant E. coli will survive in the soil to recolonize in a cow's gut through pasture, forage or bedding.
Axis Surgical Technologies, Inc., reports the first evaluation of the C-MOR™ Visualization Device in a spine procedure. The C-MOR™ is a self-contained portable direct-imaging tool that functions much like a standard arthroscopic tower, yet at a fraction of both the size and cost. The handheld lightweight device offers practitioners the convenience of intraoperative visualization and complete operability in one hand. The C-MOR™ comprises a distinctive and cost-effective imaging device offering benefits to medical practitioners in a variety of applications, including lengthy surgeries requiring constant re-evaluation of the operating field over the course of the surgery.
Anacor Pharmaceuticals, a privately held pharmaceutical company, has announced that the journal Science will publish results of research that details how AN2690, the company's lead clinical candidate, kills fungal cells by interfering with synthesis of a specific protein required for fungal growth.
Researchers at Brigham and Women's Hospital have found two new potential drug targets for treating arterial diseases such as atherosclerosis.
› Verified 2 days ago